{"disease":{"id":"gvhd-acute","name":"gvhd acute"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04284904","title":"Role of aGVHD Biomarkers on aGVHD Risks","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT01295710","title":"Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Neovii Biotech","has_results":true},{"nct_id":"NCT07340723","title":"Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":168,"lead_sponsor_name":"Daihong Liu","has_results":false},{"nct_id":"NCT05263999","title":"A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":158,"lead_sponsor_name":"Equillium","has_results":false},{"nct_id":"NCT03042676","title":"Electronic Database for the Follow up of the ATG_FamilyStudy","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05718791","title":"CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT04522843","title":"Analysis of Intestinal Defensin Expression in Acute GVHD","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT06075225","title":"MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Sichuan University","has_results":false},{"nct_id":"NCT05368181","title":"MAP-guided Preemptive Therapy of aGvHD","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Sichuan University","has_results":false},{"nct_id":"NCT07509749","title":"Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"Daihong Liu","has_results":false},{"nct_id":"NCT04118556","title":"Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Mats Remberger","has_results":false},{"nct_id":"NCT03605927","title":"CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":false},{"nct_id":"NCT06904482","title":"Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06462365","title":"Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tr1X, Inc.","has_results":false},{"nct_id":"NCT03763318","title":"A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Equillium","has_results":true},{"nct_id":"NCT04473911","title":"Haplo Peripheral Blood Sct In GVHD Prevention","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Zachariah Michael DeFilipp","has_results":false},{"nct_id":"NCT04118075","title":"PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT01523821","title":"Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT06164288","title":"Safety and Efficacy Study of hAESCs Therapy for aGVHD","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China","has_results":false},{"nct_id":"NCT05401955","title":"Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT07350057","title":"A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04220632","title":"A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT05443464","title":"Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ossium Health, Inc.","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}